Cota Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Puracathpuracath.comJun 2020
PuraCath Medical develops disinfection technology for catheter connections designed to reduce infection risk in healthcare settings.
BiotechHealthtechMedical DevicesSilicon Valley, US
Julia Rasooly(CEO)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.